Notice of Open Public Hearing, 34254 [2019-15245]
Download as PDF
<![CDATA[
34254
Federal Register / Vol. 84, No. 137 / Wednesday, July 17, 2019 / Notices
Issued on: July 10, 2019.
Linda M. Gehrke,
Regional Administrator.
the relevant sanctions authority listed
below.
Entity
[FR Doc. 2019–15156 Filed 7–16–19; 8:45 am]
1. GENERAL DIRECTORATE OF
MILITARY COUNTERINTELLIGENCE (a.k.a.
DGCIM; a.k.a. DIRECCION GENERAL DE
CONTRAINTELIGENCIA MILITAR (Latin:
´ N GENERAL DE
DIRECCIO
CONTRAINTELIGENCIA MILITAR)),
Caracas, Capital District, Venezuela
[VENEZUELA–EO13850].
BILLING CODE P
DEPARTMENT OF THE TREASURY
Office of Foreign Assets Control
Notice of OFAC Sanctions Action
Office of Foreign Assets
Control, Treasury.
ACTION: Notice.
AGENCY:
The Department of the
Treasury’s Office of Foreign Assets
Control (OFAC) is publishing the names
of one or more persons that have been
placed on OFAC’s Specially Designated
Nationals and Blocked Persons List
based on OFAC’s determination that one
or more applicable legal criteria were
satisfied. All property and interests in
property subject to U.S. jurisdiction of
this person are blocked, and U.S.
persons are generally prohibited from
engaging in transactions with them.
DATES: See SUPPLEMENTARY INFORMATION
section.
FOR FURTHER INFORMATION CONTACT:
OFAC: Associate Director for Global
Targeting, tel.: 202–622–2420; Assistant
Director for Sanctions Compliance &
Evaluation, tel.: 202–622–2490;
Assistant Director for Licensing, tel.:
202–622–2480; Assistant Director for
Regulatory Affairs, tel.: 202–622–4855;
or the Department of the Treasury’s
Office of the General Counsel: Office of
the Chief Counsel (Foreign Assets
Control), tel.: 202–622–2410.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Electronic Availability
The Specially Designated Nationals
and Blocked Persons List and additional
information concerning OFAC sanctions
programs are available on OFAC’s
website (https://www.treasury.gov/ofac).
Notice of OFAC Action
jbell on DSK3GLQ082PROD with NOTICES
On July 11, 2019, OFAC determined
that the property and interests in
property subject to U.S. jurisdiction of
the following person are blocked under
VerDate Sep<11>2014
18:05 Jul 16, 2019
Jkt 247001
Designated pursuant to section 1(a)(i)
of Executive Order 13850 (E.O. 13850)
of November 1, 2018, ‘‘Blocking
Property of Additional Persons
Contributing to the Situation in
Venezuela,’’ as amended by Executive
Order 13857, ‘‘Taking Additional Steps
to Address the National Emergency with
Respect to Venezuela,’’ of January 25,
2019, for operating in the defense and
security sector of the Venezuelan
economy.
Dated: July 11, 2019.
Andrea Gacki,
Director, Office of Foreign Assets Control.
[FR Doc. 2019–15207 Filed 7–16–19; 8:45 am]
BILLING CODE 4810–AL–P
U.S.-CHINA ECONOMIC AND
SECURITY REVIEW COMMISSION
Notice of Open Public Hearing
U.S.-China Economic and
Security Review Commission.
ACTION: Notice of open public hearing.
AGENCY:
Notice is hereby given of the
following hearing of the U.S.-China
Economic and Security Review
Commission.
The Commission is mandated by
Congress to investigate, assess, and
report to Congress annually on ‘‘the
national security implications of the
economic relationship between the
United States and the People’s Republic
of China.’’ Pursuant to this mandate, the
Commission will hold a public hearing
in Washington, DC on July 31, 2019 on
‘‘Exploring the Growing U.S. Reliance
on China’s Biotech and Pharmaceutical
Products.’’
DATES: The hearing is scheduled for
Wednesday, July 31, 2019 at 9:00 a.m.
SUMMARY:
PO 00000
Frm 00139
Fmt 4703
Sfmt 9990
428A Russell Senate Office
Building, Washington, DC. A detailed
agenda for the hearing will be posted on
the Commission’s website at
www.uscc.gov. Also, please check the
Commission’s website for possible
changes to the hearing schedule.
Reservations are not required to attend
the hearing.
ADDRESSES:
Any
member of the public seeking further
information concerning the hearing
should contact Leslie Tisdale Reagan,
444 North Capitol Street NW, Suite 602,
Washington, DC 20001; telephone: 202–
624–1496, or via email at lreagan@
uscc.gov. Reservations are not required
to attend the hearing.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Background: This is the seventh
public hearing the Commission will
hold during its 2019 report cycle. The
hearing will assess China’s role in global
health industries and implications for
U.S. health, biotech, pharmaceutical
firms, and the U.S. public. The hearing
will also examine the activities of
Chinese health and biotech firms in the
United States and the ability of U.S.
health and biotech firms to access the
China market. The hearing will be cochaired by Senator James Talent and
Commissioner Michael Wessel. Any
interested party may file a written
statement by July 31, 2019 by mailing to
the contact above. A portion of each
panel will include a question and
answer period between the
Commissioners and the witnesses.
Authority: Congress created the U.S.China Economic and Security Review
Commission in 2000 in the National
Defense Authorization Act (Pub. L. 106–
398), as amended by Division P of the
Consolidated Appropriations
Resolution, 2003 (Pub. L. 108–7), as
amended by Public Law 109–108
(November 22, 2005), as amended by
Public Law 113–291 (December 19,
2014).
Dated: July 12, 2019.
Daniel W. Peck,
Executive Director, U.S.-China Economic and
Security Review Commission.
[FR Doc. 2019–15245 Filed 7–16–19; 8:45 am]
BILLING CODE 1137–00–P
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 84, Number 137 (Wednesday, July 17, 2019)]
[Notices]
[Page 34254]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15245]
=======================================================================
-----------------------------------------------------------------------
U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION
Notice of Open Public Hearing
AGENCY: U.S.-China Economic and Security Review Commission.
ACTION: Notice of open public hearing.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given of the following hearing of the U.S.-
China Economic and Security Review Commission.
The Commission is mandated by Congress to investigate, assess, and
report to Congress annually on ``the national security implications of
the economic relationship between the United States and the People's
Republic of China.'' Pursuant to this mandate, the Commission will hold
a public hearing in Washington, DC on July 31, 2019 on ``Exploring the
Growing U.S. Reliance on China's Biotech and Pharmaceutical Products.''
DATES: The hearing is scheduled for Wednesday, July 31, 2019 at 9:00
a.m.
ADDRESSES: 428A Russell Senate Office Building, Washington, DC. A
detailed agenda for the hearing will be posted on the Commission's
website at www.uscc.gov. Also, please check the Commission's website
for possible changes to the hearing schedule. Reservations are not
required to attend the hearing.
FOR FURTHER INFORMATION CONTACT: Any member of the public seeking
further information concerning the hearing should contact Leslie
Tisdale Reagan, 444 North Capitol Street NW, Suite 602, Washington, DC
20001; telephone: 202-624-1496, or via email at [email protected].
Reservations are not required to attend the hearing.
SUPPLEMENTARY INFORMATION:
Background: This is the seventh public hearing the Commission will
hold during its 2019 report cycle. The hearing will assess China's role
in global health industries and implications for U.S. health, biotech,
pharmaceutical firms, and the U.S. public. The hearing will also
examine the activities of Chinese health and biotech firms in the
United States and the ability of U.S. health and biotech firms to
access the China market. The hearing will be co-chaired by Senator
James Talent and Commissioner Michael Wessel. Any interested party may
file a written statement by July 31, 2019 by mailing to the contact
above. A portion of each panel will include a question and answer
period between the Commissioners and the witnesses.
Authority: Congress created the U.S.-China Economic and Security
Review Commission in 2000 in the National Defense Authorization Act
(Pub. L. 106-398), as amended by Division P of the Consolidated
Appropriations Resolution, 2003 (Pub. L. 108-7), as amended by Public
Law 109-108 (November 22, 2005), as amended by Public Law 113-291
(December 19, 2014).
Dated: July 12, 2019.
Daniel W. Peck,
Executive Director, U.S.-China Economic and Security Review Commission.
[FR Doc. 2019-15245 Filed 7-16-19; 8:45 am]
BILLING CODE 1137-00-P
